Patent details

301088 Product Name: Sacubitril/valsartan, als sacubitril valsartan natriumzoutcomplex, dat wil zeggen [((S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)-bifenyl-4-yl]-methyl}-valine) ((2R,4S)-5-bifenyl-4-yl-4-(3-carboxypropionylamino)-2-methyl-pentaanzuurethylester)]Na3·x H2O, waarbij x 0 tot en met 3 is.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301088
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2340828
Status:
Withdrawn
Application number:
301088
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1058
Marketing Authorization Type:
EEA
Marketing Authorization Date:
23/11/2015
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
13/01/2021
First Marketing Authorization date:
23/11/2015
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
14/01/2021
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
15/05/2025
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
13/01/2021
 
 

 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Agent

1

Name:
ir. B.Ch. Ledeboer c.s
From:
09/01/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. H.A. Witmans c.s.
From:
13/01/2021
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
09/01/2025

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
41/25
Publication date:
08/10/2025
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
03/21
Publication date:
20/01/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
06/10/2025 Outgoing Correspondence Letter confirmation withdrawal 1 PDF /1/0/4/4/4/0800644401/docs/301088_12_301088676943l193.pdf
15/05/2025 SPC Documents SPC Documents 1 PDF /1/0/4/4/4/0800644401/docs/301088_11_supplprotectioncertificate20250516083500024.pdf
14/01/2021 Outgoing Correspondence Confirmation receipt request 1 PDF /1/0/4/4/4/0800644401/docs/301088_10_389328l174.pdf
13/01/2021 SPC Documents Marketing Authorization SPC 3 PDF /1/0/4/4/4/0800644401/docs/301088_0_supplprotectioncertificate20210114083020235.pdf
13/01/2021 SPC Documents Annex SPC 2 PDF /1/0/4/4/4/0800644401/docs/301088_1_supplprotectioncertificate20210114084207221.pdf
13/01/2021 SPC Documents Accompanying letter SPC 8 PDF /1/0/4/4/4/0800644401/docs/301088_2_supplprotectioncertificate20210114082904199.pdf
13/01/2021 SPC Documents Annex SPC 115 PDF /1/0/4/4/4/0800644401/docs/301088_3_supplprotectioncertificate20210114084019791.pdf
13/01/2021 SPC Documents Annex SPC 2 PDF /1/0/4/4/4/0800644401/docs/301088_4_supplprotectioncertificate20210114083428647.pdf
13/01/2021 SPC Documents Annex SPC 1 PDF /1/0/4/4/4/0800644401/docs/301088_5_supplprotectioncertificate20210114084134421.pdf
13/01/2021 SPC Documents Annex SPC 28 PDF /1/0/4/4/4/0800644401/docs/301088_6_supplprotectioncertificate20210114083635360.pdf
13/01/2021 SPC Documents Annex SPC 2 PDF /1/0/4/4/4/0800644401/docs/301088_7_supplprotectioncertificate20210114083827252.pdf
13/01/2021 SPC Documents Summary of the characteristics of the product 20 PDF /1/0/4/4/4/0800644401/docs/301088_8_supplprotectioncertificate20210114083245780.pdf
13/01/2021 Application Form First filed application form 3 PDF /1/0/4/4/4/0800644401/docs/301088_9_applicationform20210114082608127.pdf